Stay updated with breaking news from 46433010. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) has been assigned a consensus rating of “Hold” from the thirteen analysts that are presently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating, six have given a buy rating and one […]
StockNews.com cut shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) from a hold rating to a sell rating in a research report report published on Tuesday. IONS has been the topic of a number of other reports. Morgan Stanley lifted their price objective on shares of Ionis Pharmaceuticals from $45.00 to $48.00 and gave the […]
StockNews.com downgraded shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) from a hold rating to a sell rating in a report released on Tuesday morning. A number of other research firms have also issued reports on IONS. Raymond James started coverage on Ionis Pharmaceuticals in a report on Thursday, September 28th. They issued a strong-buy […]
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) and CureVac (NASDAQ:CVAC – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership. Analyst Ratings This is a breakdown of recent ratings […]
StockNews.com upgraded shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) from a sell rating to a hold rating in a research note released on Monday morning. IONS has been the topic of a number of other reports. Bank of America upgraded shares of Ionis Pharmaceuticals from an underperform rating to a neutral rating and increased […]